Dofetilide and Goserelin: Interaction Details

Brand names
Dofetilide
Tikosyn
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Goserelin

We don't have a drug information page for Goserelin yet. Have a question about Goserelin? Ask a pharmacist, free →

What Happens When You Take Dofetilide With Goserelin

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Giving goserelin together with other drugs that prolong the produces effects on QT. Androgen deprivation from GnRH or can itself lengthen the QT interval.

In patients with congenital long QT syndrome, congestive heart failure, or frequent electrolyte abnormalities, and in those receiving drugs known to prolong the QT interval, it is worth weighing whether the benefits of androgen deprivation therapy such as goserelin exceed the possible risks.3 Where possible, goserelin should not be combined with QT prolonging agents. When combined use cannot be avoided, drugs that induce electrolyte abnormalities (ie, or ) should be avoided,1 existing electrolyte abnormalities should be corrected, and periodic and electrolyte monitoring should be considered.3

The Dofetilide and Goserelin Interaction, Explained

Both of these medicines can affect your heart's electrical rhythm. Dofetilide (Tikosyn) helps control atrial fibrillation, but it can lengthen the heart's recharge time, called the . Goserelin lowers testosterone, usually for prostate or breast cancer, and this may also lengthen the QT interval a little.

Taken together, the effects may add up and raise the chance of a dangerous heart rhythm. This is based on theory, not on many reported cases, but dofetilide is a drug where heart rhythm really matters. Please keep taking both as prescribed. Your care team can check your heart tracing () and your potassium and magnesium levels, and decide if this combination is right for you. Tell them about any fainting, dizziness, or racing heartbeat.

(). Dofetilide is a potent IKr (hERG) blocker with dose-dependent QTc prolongation and risk. Androgen deprivation therapy with GnRH such as goserelin may also prolong QT. Evidence is theoretical; onset is unspecified; severity is rated major.

  • Weigh ADT benefit against risk, especially with congenital long QT, heart failure, or recurrent electrolyte disturbances.
  • Avoid when possible.
  • If required, avoid agents causing or , and correct electrolytes.
  • Consider periodic and electrolyte monitoring, with attention to and function per dofetilide labeling.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dofetilide and Goserelin Interact

The likely mechanism

In short: Dofetilide and goserelin both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Dofetilide and Goserelin Interaction

Your care team will first weigh whether the benefits of goserelin outweigh the risks for you, and they avoid combining QT-prolonging drugs when they can. If you need both, they may check your electrolytes (potassium and magnesium), correct any that are low, and monitor your heart tracing () periodically.

  • Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
  • Ask before using any new medicine that could lower potassium or magnesium.
  • Report fainting, dizziness, palpitations, or severe vomiting or diarrhea right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dofetilide or Goserelin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes

    A study of male patients receiving androgen deprivation therapy (ADT) analyzed individual case safety reports in VigiBase, the international pharmacovigilance database, and identified 184 cases of acquired long-QT syndrome (aLQTS) and/or (TdP; 11% fatal) and 99 cases of sudden death associated with ADT. Most ADT-associated cases of aLQTS/TdP (62%) and sudden death (88%) occurred without exposure to other drugs known to raise TdP risk.

    Nevertheless, some aLQTS/TdP events (23% or 43%) and sudden death events (18% and 22%) involved exposure to 1 drug and to 2 or more drugs, respectively, carrying a conditional, possible, or known TdP risk. The drugs counted as ADTs were abiraterone, gonadotropin-releasing hormone and , nonsteroidal androgen receptor indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism.

    Seven of the 10 ADTs evaluated showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death: leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The median patient age was about 76 years.

    The median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. Patients were mainly receiving ADT for prostate cancer, while some were treated for prostatism and androgenic alopecia. Most patients (83%) were on ADT monotherapy, and 17% were receiving ADT combination therapy.2

Dofetilide and Goserelin: Common Questions

How serious is the Dofetilide and Goserelin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Dofetilide and Goserelin interaction managed?

Your care team will first weigh whether the benefits of goserelin outweigh the risks for you, and they avoid combining QT-prolonging drugs when they can. If you need both, they may check your electrolytes (potassium and magnesium), correct any that are low, and monitor your heart tracing () periodically. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Ask be… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dofetilide and Goserelin Interaction

Ask in your own words about taking Dofetilide and Goserelin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
  2. Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
  3. Product Information: ZOLADEX® subcutaneous implant, goserelin subcutaneous implant. TerSera Therapeutics LLC, Deerfield, IL, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dofetilide and Goserelin

Also serious with Dofetilide

Also serious with Goserelin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Dofetilide

With Goserelin

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.